Stroke associated with thrombolytic therapy for acute myocardial infarction.
Sloan
M A
MA
Department of Neurology, University of Maryland Hospital, Baltimore 21201.
D002543:Cerebral Hemorrhage / Q000139:chemically induced / Q000175:diagnosis / Q000628:therapy; D002544:Cerebral Infarction / Q000139:chemically induced / Q000175:diagnosis / Q000628:therapy; D002561:Cerebrovascular Disorders / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D011379:Prognosis; D013300:Streptokinase / Q000009:adverse effects; D015912:Thrombolytic Therapy / Q000009:adverse effects*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects; D014568:Urokinase-Type Plasminogen Activator / Q000009:adverse effects
D013300:Streptokinase; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator